
Muscular and Renal Safety of Ticagrelor with High-Intensity Statins: Retrospective Cohort Findings
Introduction Ticagrelor, as the pioneering antiplatelet agent in the cyclopentyltriazolopyrimidines class, has been authorized in more than 70 countries, including the European Union and the United States, to minimize the occurrence of thrombotic events in …